95 related articles for article (PubMed ID: 12852371)
1. Worsening injection site reactions with continued use of etanercept.
Edwards KR; Mowad CM; Tyler WB
J Drugs Dermatol; 2003 Apr; 2(2):184-7. PubMed ID: 12852371
[TBL] [Abstract][Full Text] [Related]
2. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein.
Zeltser R; Valle L; Tanck C; Holyst MM; Ritchlin C; Gaspari AA
Arch Dermatol; 2001 Jul; 137(7):893-9. PubMed ID: 11453808
[TBL] [Abstract][Full Text] [Related]
3. Recall injection-site reactions associated with etanercept therapy: report of two new cases with immunohistochemical analysis.
González-López MA; Martínez-Taboada VM; González-Vela MC; Blanco R; Fernández-Llaca H; Rodríguez-Valverde V; Val-Bernal JF
Clin Exp Dermatol; 2007 Nov; 32(6):672-4. PubMed ID: 17953638
[TBL] [Abstract][Full Text] [Related]
4. Successful etanercept desensitization in a patient with severe injection site reactions.
Hall J; Findeisen J
J Clin Rheumatol; 2013 Oct; 19(7):407-8. PubMed ID: 24048103
[No Abstract] [Full Text] [Related]
5. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.
Genovese MC; Cohen S; Moreland L; Lium D; Robbins S; Newmark R; Bekker P;
Arthritis Rheum; 2004 May; 50(5):1412-9. PubMed ID: 15146410
[TBL] [Abstract][Full Text] [Related]
6. Delayed multiple injection site reaction in a rheumatoid arthritis patient treated with etanercept.
Rajakulendran S; Deighton C
Rheumatology (Oxford); 2004 Dec; 43(12):1588-9. PubMed ID: 15564639
[No Abstract] [Full Text] [Related]
7. Eosinophilic cellulitislike reaction to subcutaneous etanercept injection.
Winfield H; Lain E; Horn T; Hoskyn J
Arch Dermatol; 2006 Feb; 142(2):218-20. PubMed ID: 16490850
[TBL] [Abstract][Full Text] [Related]
8. Etanercept injection site reaction.
Clelland S; Hunek JR
Dermatol Nurs; 2005 Oct; 17(5):375-. PubMed ID: 16294944
[No Abstract] [Full Text] [Related]
9. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis.
Bliddal H; Terslev L; Qvistgaard E; Konig M; Holm CC; Rogind H; Boesen M; Danneskiold-Samsøe B; Torp-Pedersen S
Scand J Rheumatol; 2006; 35(5):341-5. PubMed ID: 17062431
[TBL] [Abstract][Full Text] [Related]
10. Etanercept-induced injection site reactions: mechanistic insights from clinical findings and immunohistochemistry.
Werth VP; Levinson AI
Arch Dermatol; 2001 Jul; 137(7):953-5. PubMed ID: 11453818
[No Abstract] [Full Text] [Related]
11. Nicolau syndrome following etanercept administration.
Guarneri C; Polimeni G
Am J Clin Dermatol; 2010; 11 Suppl 1():51-2. PubMed ID: 20586511
[TBL] [Abstract][Full Text] [Related]
12. Optic neuritis with concurrent etanercept and isoniazid therapy.
Noguera-Pons R; Borrás-Blasco J; Romero-Crespo I; Antón-Torres R; Navarro-Ruiz A; González-Ferrandez JA
Ann Pharmacother; 2005 Dec; 39(12):2131-5. PubMed ID: 16264061
[TBL] [Abstract][Full Text] [Related]
13. Parapharyngeal abscess in a patient receiving etanercept.
Borrás-Blasco J; Nuñez-Cornejo C; Gracia-Perez A; Rosique-Robles JD; Casterá MD; Viosca E; Abad FJ
Ann Pharmacother; 2007 Feb; 41(2):341-4. PubMed ID: 17227824
[TBL] [Abstract][Full Text] [Related]
14. Do the clinical responses and complications following etanercept or infliximab therapy predict similar outcomes with the other tumor necrosis factor-alpha antagonists in patients with rheumatoid arthritis?
Ang HT; Helfgott S
J Rheumatol; 2003 Nov; 30(11):2315-8. PubMed ID: 14677170
[TBL] [Abstract][Full Text] [Related]
15. Acute injection site reaction to intraarticular etanercept administration.
Arnold EL; Khanna D; Paulus H; Goodman MP
Arthritis Rheum; 2003 Jul; 48(7):2078-9. PubMed ID: 12847708
[No Abstract] [Full Text] [Related]
16. Development of pseudogout during etanercept treatment.
Josefina M; Ana CJ; Ariel V; Silvio AA
J Clin Rheumatol; 2007 Jun; 13(3):177. PubMed ID: 17551392
[No Abstract] [Full Text] [Related]
17. No evidence for increased risk of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis receiving etanercept for up to 5 years.
Lebwohl M; Blum R; Berkowitz E; Kim D; Zitnik R; Osteen C; Wallis WJ
Arch Dermatol; 2005 Jul; 141(7):861-4. PubMed ID: 16027301
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of alopecia areata in a patient receiving etanercept injections.
Posten W; Swan J
Arch Dermatol; 2005 Jun; 141(6):759-60. PubMed ID: 15967923
[TBL] [Abstract][Full Text] [Related]
19. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
Martínez-Taboada VM; Val-Bernal JF; Pesquera LC; Fernández-Llanio NE; Esteban JM; Blanco R; Alonso-Bartolome P; Gonzalez-Vela C; Rodríguez-Valverde V
Scand J Rheumatol; 2006; 35(4):322-3. PubMed ID: 16882599
[No Abstract] [Full Text] [Related]
20. Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis.
O'Dell JR; Petersen K; Leff R; Palmer W; Schned E; Blakely K; Haire C; Fernandez A
J Rheumatol; 2006 Feb; 33(2):213-8. PubMed ID: 16358366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
